Polaryx Therapeutics, Inc./$PLYX
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Polaryx Therapeutics, Inc.
Polaryx Therapeutics Inc is a clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric LSDs. Its therapeutic approach focuses on treating the underlying pathophysiology of these diseases and addressing unmet needs. The company's therapeutic pipeline includes PLX-200, PLX-300, and PLX-100, which are orally available small molecule drug candidates designed to address core pathological mechanisms common to LSDs.
Ticker
$PLYX
Sector
Primary listing
Employees
11
Headquarters
Website
PLYX Metrics
BasicAdvanced
$138M
-
-$0.19
-
-
Price and volume
Market cap
$138M
52-week high
$5.90
52-week low
$2.80
Financial strength
Current ratio
8.773
Quick ratio
8.424
Profitability
Management effectiveness
Valuation
Price to book
25.91
Price to tangible book (TTM)
25.91
Price to free cash flow (TTM)
-38.346
Free cash flow yield (TTM)
-2.61%
Free cash flow per share (TTM)
-0.076
Growth
PLYX Financial Performance
Revenues and expenses
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Polaryx Therapeutics, Inc. stock?
Polaryx Therapeutics, Inc. (PLYX) has a market cap of $138M as of February 13, 2026.
What is the P/E ratio for Polaryx Therapeutics, Inc. stock?
The price to earnings (P/E) ratio for Polaryx Therapeutics, Inc. (PLYX) stock is 0 as of February 13, 2026.
Does Polaryx Therapeutics, Inc. stock pay dividends?
No, Polaryx Therapeutics, Inc. (PLYX) stock does not pay dividends to its shareholders as of February 13, 2026.
When is the next Polaryx Therapeutics, Inc. dividend payment date?
Polaryx Therapeutics, Inc. (PLYX) stock does not pay dividends to its shareholders.
What is the beta indicator for Polaryx Therapeutics, Inc.?
Polaryx Therapeutics, Inc. (PLYX) does not currently have a Beta indicator.